Autoimmunity Markers Prevalence Assessed in Immune Thrombocytopenia
|
By LabMedica International staff writers Posted on 17 Dec 2019 |
|
Image: The cobas c 502 is a medium throughput clinical chemistry module that performs photometric assay tests for a wide range of analytes (Photo courtesy of Roche).
Immune thrombocytopenia (ITP) is an acquired autoimmune disorder resulting from decreased platelet production and increased platelet destruction. Platelet autoantibodies in ITP lead to both acceleration of platelet destruction in the spleen and inhibition of platelet production by bone marrow megakaryocytes.
Although current guidelines recommend against routine testing of patients with ITP for autoimmune markers in the absence of disease-specific symptoms, there is general recognition that they frequently have autoantibodies associated with other autoimmune disorders in the absence of any clinical evidence of these disorders.
A number of studies have suggested that patients with ITP have a higher prevalence than the general population of positive autoimmune markers, including (ANA), rheumatoid factor (RF), anticardiolipin antibodies (ACL) immunoglobulin G (IgG) and immunoglobulin G (IgM), red blood cell direct antiglobulin test (DAT), antithyroid peroxidase antibodies (anti-ThyPeroxAb), and lupus anticoagulant (LAC).
Hematologists at Massachusetts General Hospital (Boston, MA, USA) and their colleague performed retrospective review of patients with ITP presenting to their center from 1 January 1992 to 1 December 2015. ANA assays were performed by indirect immunofluorescence assay, using Hep-2 cells (Zeus Scientific, Inc, Branchburg, NJ, USA). ThyPeroxAb assays were performed at Quest Diagnostics (Secaucus, NJ, USA) using an immunoassay method. RF markers were measured with an immunoturbidimetric assay on a cobas c 502 platform (Roche, Basel, Switzerland). Positive results for ACL were defined as >15 for IgG phospholipid units or IgM phospholipid (MPL) units. Glycoprotein-specific direct platelet autoantibody testing was performed with the PakAuto assay (Immucor, Brookfield, WI, USA).
The scientists reported that there was a high rate of autoimmune marker positivity in this population, with antinuclear antibody (65%), antithyroid peroxidase antibody (31%), and direct antiglobulin (29%) the most commonly found. Antithyroid peroxidase antibody positivity was associated with a lower probability of remission (odds ratio [OR], 0.26). Lupus anticoagulant positivity was associated with a higher rate of thrombosis (OR, 8.92), and antinuclear antibody was strongly associated with thrombosis. There was no relation between platelet autoantibody positivity and the presence of autoimmune markers.
The authors concluded that their results suggest that many patients with ITP have a state of immune dysregulation that extends beyond platelet autoantibodies and that certain autoimmune markers may be prognostically useful in this disorder. The study was published on November 15, 2019 in the journal Blood Advances.
Related Links:
Massachusetts General Hospital
Zeus Scientific
Quest Diagnostics
Roche
Immucor
Although current guidelines recommend against routine testing of patients with ITP for autoimmune markers in the absence of disease-specific symptoms, there is general recognition that they frequently have autoantibodies associated with other autoimmune disorders in the absence of any clinical evidence of these disorders.
A number of studies have suggested that patients with ITP have a higher prevalence than the general population of positive autoimmune markers, including (ANA), rheumatoid factor (RF), anticardiolipin antibodies (ACL) immunoglobulin G (IgG) and immunoglobulin G (IgM), red blood cell direct antiglobulin test (DAT), antithyroid peroxidase antibodies (anti-ThyPeroxAb), and lupus anticoagulant (LAC).
Hematologists at Massachusetts General Hospital (Boston, MA, USA) and their colleague performed retrospective review of patients with ITP presenting to their center from 1 January 1992 to 1 December 2015. ANA assays were performed by indirect immunofluorescence assay, using Hep-2 cells (Zeus Scientific, Inc, Branchburg, NJ, USA). ThyPeroxAb assays were performed at Quest Diagnostics (Secaucus, NJ, USA) using an immunoassay method. RF markers were measured with an immunoturbidimetric assay on a cobas c 502 platform (Roche, Basel, Switzerland). Positive results for ACL were defined as >15 for IgG phospholipid units or IgM phospholipid (MPL) units. Glycoprotein-specific direct platelet autoantibody testing was performed with the PakAuto assay (Immucor, Brookfield, WI, USA).
The scientists reported that there was a high rate of autoimmune marker positivity in this population, with antinuclear antibody (65%), antithyroid peroxidase antibody (31%), and direct antiglobulin (29%) the most commonly found. Antithyroid peroxidase antibody positivity was associated with a lower probability of remission (odds ratio [OR], 0.26). Lupus anticoagulant positivity was associated with a higher rate of thrombosis (OR, 8.92), and antinuclear antibody was strongly associated with thrombosis. There was no relation between platelet autoantibody positivity and the presence of autoimmune markers.
The authors concluded that their results suggest that many patients with ITP have a state of immune dysregulation that extends beyond platelet autoantibodies and that certain autoimmune markers may be prognostically useful in this disorder. The study was published on November 15, 2019 in the journal Blood Advances.
Related Links:
Massachusetts General Hospital
Zeus Scientific
Quest Diagnostics
Roche
Immucor
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
Vaginitis Test
Allplex Vaginitis Screening Assay
Latest Hematology News
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
Molecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read more
Technology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
